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Background: The objectives of this cross-sectional, observational study were to determine the prevalence of self-
reported headache among the employees of the large Swiss university hospital, to measure the impact of
headache using the MIDAS questionnaire, to assess current treatment and to estimate economic burden of
headache considering indirect costs.
Methods: A self-administered questionnaire was distributed internally to 2000 randomly selected employees of the
University Hospital Zurich.
Results: 1210 employees (60.5%) responded. Of the 1192 (98.5%) employees who provided sufficiently complete
information, 723 (61%) reported at least one headache type in the last three months. The prevalence of migraine,
and tension-type headache was 20% and 50%, respectively. Regarding the occupational groups, there was a trend
that healthcare staff, administration employees, and medical technicians suffered more from headaches than
physicians, correcting for age and sex. The economic consequences of lost productivity were calculated to amount
to approximately 14 million Swiss Francs (9.5 million EUR), representing 3.2% of the overall annual expenditure of
the hospital for personnel.
Conclusion: Headache is highly prevalent among university hospital employees, with significant economic impact.Background
Migraine is a common, chronic, potentially incapacita-
ting neurovascular headache disorder, characterized by
attacks of severe headache and autonomic nervous
system dysfunction, with a substantial effect on eco-
nomic productivity [1]. Physicians and patients often do
not realize the migraine-associated disability, which may
contribute to suboptimal management.
Primary headaches have been recognised by the World
Health Organisation as major public health problem as
they are globally prevalent in a considerable proportion
of the population, affect all ages, and have significant
impact on individuals and their society [2,3]. In the
World Health Report 2001 [4] migraine figured among
the top twenty causes of disability in the world, together* Correspondence: franz.riederer@uzh.ch
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Tension-type headache is usually less disabling than
migraine, and typically lacking accompanying symptoms
and has not yet been considered in WHO reports. The
impact of this prevalent headache type on certain suf-
ferers may be comparable to that of migraine, especially
in those suffering from the chronic form. Importantly,
from both migraine and tension headache, medication
overuse headache (MOH) can arise, if acute headache
medication is taken too often. MOH can phenotypically
resemble tension-type headache, often with some mi-
grainous features [5].
The socioeconomic significance of headache disorders
is probably underestimated, in spite of some studies
reporting their considerable impact on social activities
and work [6]. The reduction in quality of life and work
productivity due to migraine can be profound, with the
intensity of pain being the most important of severalis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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migraineurs have limitations of activity, 50% interrupt
their activities and 30% must lie down during the attack
[7,8].
Based on estimations of the global prevalence of active
headache disorders [3] the number of tension-type head-
ache and migraine sufferers in Switzerland should be
around 3.2 million and 850 000, respectively [3]. In the
Canadian population costs associated with migraine
were estimated at 2229 Canadian dollars, whereby the
major part of these expenses (1949 Canadian dollars)
is attributable to indirect costs by absence from work
and reduced productivity at work [9]. Applying these
date to the Swiss population this would mean a total
cost of 1.9 billion Canadian dollars (1.18 billion EUR,
1 EUR=1.6 Canadian Dollars in 2003) for migraine
per year.
Despite the prevalence, severity, and burden of mi-
graine, recent surveys suggest that fewer than half of
current migraine sufferers have ever received a medical
diagnosis [10]. Only one-third of migraine sufferers
currently receive treatment with prescription drugs. The
low rates of diagnosis and treatment have several causes,
including low rates of medical consultation specifically
for headache.
The main objectives of this cross-sectional observa-
tional study were to estimate (i) the prevalence of head-
ache among employees of a large university hospital, (ii)
the burden of headache -related disability using MIDAS
(iii) economic implications by calculating the estimated
indirect costs of headache.
Methods
This is a cross-sectional survey of a sample of university
hospital employees using a self-administered question-
naire. After approval of the Hospital Board and Ethics
Committee, a questionnaire was sent to randomly chosenTable 1 Items from headache questionnaires related to heada
a) Headache is
b) Headache is
c) Daily activities are impaired (can still be performed) but not inhibited
(cannot be performed anymore)
d) Headache worsened by physical activity
e) Nausea
f) Vomitting
g) Sensitivity to light
h) Sensitivity to noise
i) One or more completely reversible neurologic deficiencies (impaired vision2000 of 5525 employees of the university hospital from
December 2002 to March 2003. This sample size was
chosen prospectively assuming a response rate of 70% to
allow confidence intervals of less than 5% either side of es-
timated headache prevalence. The hospital’s internal mail
system was used for sending questionnaires and return
envelopes. The study was announced on the university
hospital intranet, a platform accessible to all employees,
and a reminder to send back missing questionnaires was
placed one month after the study start. Additionally, the
announcement was placed in the show-case at the hospital
entrance.
Outcome measures
Participants were asked in a self-administered question-
naire if they had headache and / or migraine in the last
3 months. Those participants who responded with “yes”
were asked to continue the 2 page questionnaire to pro-
vide information on:
 Diagnosis of migraine and tension-type headache,
based on the criteria of the International Headache
Society (IHS) [11]. Items related to headache
diagnosis are presented in Table 1.
 headache days per month in the last 6 months
 family history of headache
 headache duration in years
 socio-demographic status (age, gender, occupation),
 consultation of headache specialists
 “double burden” of professional and family
commitments,
 working hours per week
 impact on productivity at work, home and social
activity as quantified with the migraine disability
score (MIDAS) excluding the additional question B:che
or spOn a scale of 0 – 10 on average how painful were
these headaches [12,13].diagnosis
Type 1: Type 2:
□ one-sided □ bilateral □ one-sided □ bilateral
□ pulsating/throbbing □ pulsating/throbbing
□ dull/pressing □ dull/pressing
□ yes □ no □ yes □ no
□ yes □ no □ yes □ no
□ yes □ no □ yes □ no
□ yes □ no □ yes □ no
□ yes □ no □ yes □ no
□ yes □ no □ yes □ no
eech disorder) □ yes □ no □ yes □ no
Figure 1 Comparison of age (a), gender (b) and occupation (c) among the 1192 respondents and all university hospital employees (in %).
(b) Comparison of gender distribution among the 1192 respondents with those of University hospital employees (in %). (c) Comparison of distribution
of occupation in the sample of 1192 respondents with the distribution of occupation of the university hospital employees in total (in %).
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disability and economic costs
Main outcome measures for headache related disability
were workdays lost and reduced effectiveness at work
and home due to headaches. The MIDAS score is the
sum of missed days due to headache in the last threeFigure 2 Flow chart of the study: Participation and sample characterimonths from paid work, household work, non-work
activities, plus days at paid work and in household work
where productivity was reduced by at least half. The
4-point grading system for MIDAS Questionnaire is as
follows: grade 1 (scores ranging from 0 to 5) = little or no
disability; grade 2 (scores ranging from 6 to 10) = mildstics.
Table 2 Median age among different types of headache
and gender (n=1192)
Main headache type median (IQR)
Gender Migraine Tension Other
Female 38 (31–46) 37 (29–44) 35 (30–42)
Male 38 (32–50) 38 (34–45) 37 (29–43)
The inter quartile ranges (IQR) are given in brackets.
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rate disability; grade 4 (score ≥ 21) = severe disability [14].
The average wages were calculated on the basis of the
annual reports (average of 2000–2002 data) of the Univer-
sity Hospital according to the occupation, as stated in the
questionnaire. The daily wages were calculated by dividing
the annual income by 220 working days. The human
capital approach was used for estimation of indirect costs
[15], based on information from the MIDAS questionnaire
(which covers the last 3 months).Statistical analysis
The questionnaire allowed respondents to be dichoto-
mised as to whether they had or had not suffered from
headache in the preceding 3 months. Up to two types of
headaches could be reported and the number of patients
with “at least” one type of headache was calculated, irre-


















Figure 3 Percentage of employees with headache distributed accordi
was at trend that healthcare staff, administration, and medical technicians
numbers of respondents are given on the respective columns.in the sample (3 month prevalence). SPSS for Windows
(version 10.0) was used to perform all the computations.
Continuous variables were expressed in descriptive
terms, stating medians, means, interquartile ranges
(IQR) and 95% confidence intervals. The assessment of
univariate associations between candidate predictors and
outcomes of interest was conducted as follows: (i) chi-
square when exposures and outcomes were categorical,
(ii) t-tests, Mann–Whitney-tests and analyses of variance
resp. Kruskal-Wallis tests when one or more variables
were continuous (depending on normality of data), (iii)
correlation coefficients when both variables were continu-
ous. Logistic regression was used to assess the association
between outcome and several predictors, indicating odds
ratios with 95% confidence intervals (CI). Two tailed
p<0.05 was used as the level of statistical significance.
Results
Sample representativeness
Of the 2000 randomly addressed employees who received
the questionnaire, 1210 (60.5%) responded, but only 397
men and 795 women provided information on age and gen-
der. The data from these 1192 respondents were analysed,
though there were still omissions of information in some
categories. As shown in Figures 1a - c., the distribution of
age, gender and occupation amongst respondents to the
questionnaire is comparable to the distribution amongst






ng to occupational groups. After correction for age and sex there
suffered more from headaches than physicians. See text. The absolute
Table 4 Physician consultations in headache sufferers
Physician consulted Women Men Total
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hospital employees.N (%) N (%) N (%)
General practitioner 98 (9) 33 (17) 131 (18)
Internist 16 (3) 7 (4) 23 (3)
Neurologist 21 (4) 3 (2) 24 (3)
Other 15 (2) 5 (3) 20 (3)
None 375 (71) 147 (75) 522 (73)
Table 5 Medication use in headache sufferers
Main headache type N (%)
Medication Migraine Tension Other Headache
Women
No medication 40 (23) 121 (40) 9 (25) 170 (34)Headache prevalence and socio-demographic variation
Figure 2 shows a flow chart of the study with participa-
tion and sample characteristics. Of the 1192 employees
who provided sufficiently complete information, 723
(61%) reported at least one headache type in the three
months before completing the questionnaire. 292 (24%)
of respondents reported more than one type of headache
in the previous three months (227 females and 71
males). The 3 month prevalence was 20% (women 24%,
men 13%) for migraine and 50% (women 55%, men 40%)
for tension-type headache, considering both types of
headache. Fourteen% of responders suffered from
migraine and tension-type headache.
Median age of female and male respondents suffering
from migraine or tension-type headache was not signifi-
cantly different (Table 2). Participants who did not report
having headache were somewhat older (median 40 years,
IQR 34–48), though not significantly. The majority of the
female headache sufferers were in the youngest age-group
18–35 (45%), followed by 39% aged between 36 and
50 years, whereas only 16% of female headache sufferers
were 51 and older. Half of the male headache sufferers
were in the age group between 36 and 50 years (50%),
followed by 36% in the youngest group and 14% male
headache sufferers were 51 and older.
In absolute numbers, the health care-staff suffered
more from headaches than any other occupational group
(Figure 3). Logistic regression revealed a strong associ-
ation with age (p<0.001) and sex (p<0.001). There was a
trend that healthcare staff, (OR 1.51, 95% CI 1.05-2.2,
p=0.028), administration employees (OR 1.61, 95% CI
1.00-2.60, p=0.048) and medical technicians (OR 1.50
95% CI 0.95-2.63, p=0.080) suffered more from head-
aches than physicians; however these trends did not
survive correction for multiple comparisons.
Median monthly frequency of type 1 headache in the
preceding 6 months was 3 days (IQR 2–6). There was a
trend towards higher frequencies in the older age group,Table 3 Monthly frequency of main headache type
among age categories and gender in the the preceding
six months (n=1192)
Main headache type median (IQR)
Migraine Tension Other
Age category 18 – 35 3 (2–5) 3 (2–6) 3 (1–6)
36 – 50 4 (2–6) 3 (2–5) 2 (2–5)
51 – 65 5 (2–8) 3 (2–5) 8 (3–10)
Gender Female 4 (2–6) 3 (2–5) 5 (2–7)
Male 4 (2–7) 3 (2–5) 2 (1–5)especially in individuals with other types of headache.
However, this was not statistically significant (Table 3).
A family history of headache was reported by 428
(59%) of all headache sufferers, mainly females (76%).
The median time since onset of headache was 10 years
(IQR 5–20), with only little gender differences. A total of
295 headache sufferers (42%) reported a double burden
of having family as well as professional commitments
with no significant differences between women (224/
513; 44%) and men (71/191; 37%; p=0.123).Medical resources used and medication
Only 27% of the employees, who reported headache, had
ever consulted a physician, mainly a general practitioner.
Only 4% of women and 2% of men had ever consulted a
neurologist. (Table 4). As expected, the individuals with
higher headache frequency (p=0.009), and higher disability
scores (p=0.001), showed higher tendency to consult the
physicians.
About one third of headache sufferers used no medica-
tion. Over the counter drugs were used most frequently,
specific migraine medications such as triptans or prophy-
laxic medication only by a small minority (Table 5).OTC* 72 (42) 120 (40) 23 (63) 215 (42)
Prescription 49 (28) 55 (19) 3 (8) 107 (21)
Triptans 8 (5) 2 (1) 1 (3) 11 (2)
Prophylaxis 3 (2) 0 0 3 (0)
Men
No medication 7 (16) 32 (29) 12 (40) 51 (28)
OTC* 22 (49) 56 (51) 12 (40) 90 (49)
Prescription 10 (22) 21 (19) 5 (17) 36 (20)
Triptans 4 (9) 0 0 (0) 4 (2)
Prophylaxis 2 (4) 0 1 (3) 3 (2)













% of respondents with headache
30 40 50 60 70
Tension
Migraine
Figure 4 MIDAS grades in respondents with migraine and tension-type headache employed in a Swiss university hospital. Grade 1
(scores 0–5) = little or no disability; grade 2 (scores 6–10) = mild disability; grade 3 (scores 11–20) = moderate disability; grade 4 (score ≥ 21) =
severe disability [14]. There was significant association between headache diagnosis and MIDAS grade (p<0.001).
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Median MIDAS score in headache sufferers was 4 (IQR
1–10). The MIDAS grades in respondents with migraine
and tension-type headache are shown in Figure 4. There
was significant association between headache diagnosis
and MIDAS grade (p<0.001).
In regression analyses, association of each variable with
MIDAS score was examined. Significant independent as-
sociations with the MIDAS score were observed for head-
ache frequency, family history, double burden,
medication- use, number of working hours per month and
physician consultation. These variables explained 16% of
the variation of the MIDAS score (p=0.001; r [2]=0.16).
None of the other variables explained variability in
MIDAS score. This was unexpected for demographic
characteristics.
Over 60% of all headache sufferers reported to be full-
time employed, the rest part-time. Mean number of
workdays lost due to headache in the previous 3 months
was 0.65 (95% CI: 0.57-0.73) in headache sufferers. The
reported mean reduction of productivity by 50% in the
preceding three months because of headaches was
2.2 days (95% CI: 1.97; 2.49).
The individuals with migraine/headache reported, that
the mean number of days, on which they were not able
to do housework, was 1.60 in the previous three months
(95% CI: 1.39; 1.89). Household work was reduced by
50% on 2.12 days (95% CI: 1.86; 2.38), and social/leisure
activities were missed on 2.37 days (95% CI: 2.07; 2.67)
on average in the preceding three months.
Extrapolation of patient self-reported work and prod-
uctivity loss for the last three months to an annual basis
suggested that individuals with headaches lose 10.2
workday equivalents per year (2.4 days from absen-teeism, 7.8 days with ≥ 50% loss in productivity while at
work, counted as full days lost, ignoring days with < 50%
productivity loss [16]). Taking the average wages of the
headache sufferers (CHF 408.4/person/day) into account,
the annual costs of lost labour days was estimated at
CHF 980.18 (662.28 EUR; 1 EUR=1.48 CHF in 2003)
whereas the annual loss of productivity accounts for
another CHF 30185.60 (20152.43 EUR). On the basis of
the results obtained, and assuming that the study sample
is representative of the employees as a whole (N=5525),
it is possible to estimate the overall economic impact on
the university hospital based on the average days off
work in employees with headache and the prevalence of
headache (61%). The economic consequences of this
productivity loss may thus equal approximately 14 mil-
lion Swiss Francs (9.5 million EUR), representing 3.2% of
the overall annual personnel expenditure of the hospital.
Discussion
The three month prevalence of self-reported headache
was 61% in this hospital-based sample. The high preva-
lence of migraine in our sample (20%) can be explained
at least in part, by the fact that about 70% of employees
were female (Figure 1b). Furthermore, age distribution
in the workplace setting of our study (Figure 1b) is pro-
bably shifted towards younger ages, where migraine is
more prevalent compared to the general population.
Finally, the high prevalence of migraine the hospital
setting gives rise to speculations that this is a particularly
stressful environment since stress is a frequent trigger
factor for migraine attacks [17]. Taking into account the
influence of sex and age, there was a trend towards
higher headache prevalence among the health care staff,
administration employees, and medical technicians,
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demanding.
In accordance with previous studies, we found a female
preponderance for migraine and tension-type headache
and lower prevalence in older age groups [18,19].
Less than one third of headache sufferers in our sam-
ple had consulted physicians for their headaches. We
found that even in the hospital environment that offers
plenty of medical facilities, headache specialists, such as
neurologists, are consulted only rarely. A significant
proportion of headache and migraine sufferers had only
consulted primary care physicians. This is in accordance
with previous studies [20-22]. Also in accordance with
previous evidence [23-25] only a minority of migraine
sufferers used migraine-specific agents (triptans) or
prophylactic medication in our sample.
The economic impact of migraine and other headache-
associated disorders can be considered in terms of the
direct and indirect costs. The direct costs are those related
to the costs of the medications and the time of any
healthcare personnel involved in treatments (most of
which are estimated arbitrarily in the form of fixed reim-
bursement fees); because such a large proportion of
migraine sufferers do not even register in any account of
healthcare activity, the overall burden of direct costs is
almost impossible to estimate [26]. The indirect costs are
those associated with absence from work and reduced
effectiveness while at work. Because prevalence of mi-
graine peaks during the most productive years of life,
between ages of 25 and 55, it is an important cause of lost
work time. Indirect costs account for more than 80% of
economic burden [27,28]. We estimated the economic
consequences of productivity loss (indirect costs) related
to headache in the university hospital to 14 million CHF
(9.5 million EUR), representing 3.2% of the overall annual
personnel expenditure. Annual indirect costs per head-
ache sufferer (CHF 4165.68 = EUR 2814.72) were higher
than the costs of migraine in Europe, which were esti-
mated at EUR 1222 (93% of this amount are indirect
costs) in a recent study [29]. The discrepancy may be
explained by the populations studied (work place setting
versus general population) and differences in wage levels.
Distribution of MIDAS grades was different between
migraine and tension-type headache: More tension-type
headache sufferers had MIDAS grade 1, while more mi-
graine sufferers had MIDAS grades 2–4. We found a
positive correlation of missed days of work and days
with decreased productivity with the increased grade of
MIDAS score. MIDAS, a measure of headache related
disability, was associated with double burden (profes-
sional and family commitments) and number of working
hours per month in addition to indicators of migraine
severity such as headache frequency, medication use or
physician consultation.Several shortcomings of our study merit discussion.
First, the 60.5% responder rate may address the question
of participation bias. Although, representativeness of the
sample was shown, as the responders and non-responders
distribution with respect to age and gender were compa-
rable, participation bias cannot be fully excluded. As the
focus of the study was headache related disability and cost
in general, we only considered headache as such for eco-
nomic estimations, irrespective of type. Therefore possible
diagnostic problems of self-administered questionnaires
can be considered negligible in this context. Conclusions
from the present study conducted in the environment of a
large university hospital may not be comparable to other
workplace settings with different organisation of work and
wage levels.
Finally, a limitation of our study is the use of the
human capital method, according to which production
losses are valued using average earnings, whereas actual
loss to society may be much smaller. Migraine and
tension type headache led to short-time absences that
may not result in production loss: the work may be
covered by others or made up by the headache sufferer
on his return to work.
The strengths of the study include the large sample
size.
Population-based studies reveal that migraine is cur-
rently under-diagnosed and under-treated as a whole,
but estimation of the distribution and magnitude of the
impact of headache in the workplace is necessary before
public health interventions can be developed.
Conclusion
In conclusion, headache is a highly prevalent condition
among university hospital employees, with significant
impact on both, professional and social functioning. There
is a substantial economic burden of headache from an
employer perspective. Our findings suggest that effective
diagnosis and treatment of migraine could contribute
substantially to reduce the indirect cost associated with
this disabling disorder.
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